immunogens with improved solubility

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9101560
APP PUB NO 20130323274A1
SERIAL NO

13904855

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Variants of the pathogenic E. coli ‘AcfD precursor’ have been identified with increased solubility as compared to the native AcfD protein that raise a substantially similar immune response in a subject as the native AcfD protein.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • GLAXOSMITHKLINE BIOLOGICALS SA

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Fontana, Maria Rita Siena, IT 19 229
Gomes, Moriel Danilo Siena, IT 7 2
Pizza, Mariagrazia Siena, IT 129 2084
Serino, Laura Monticiano, IT 17 184

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 11, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00